ALS LTD (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ - ALS LTD

Year End: March
GICS Industry Group : Commercial & Professional Services
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$10.09

15 Apr
2021

-0.050

OPEN

$10.17

-0.49%

HIGH

$10.17

774,413

LOW

$9.90

TARGET
$10.181 0.9% upside
Franking for last dividend paid out: 70%
OTHER COMPANIES IN THE SAME SECTOR
CIM . DOW . TPI . TSE . WTP . EVS . BIN . SSM . SND . CWY . CVL . EGN . BSA . HRL . FLC . PTB . CG1 . MAD . PPK . SDV . LBL . VEE .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY19
Actual
FY20
Actual
FY21
Forecast
FY22
Forecast
EPS (cps) xxx 15.3 37.2 xxx
DPS (cps) xxx 17.6 19.0 xxx
EPS Growth xxx - 51.7% 100.0% xxx
DPS Growth xxx - 21.8% 8.1% xxx
PE Ratio xxx N/A 27.2 xxx
Dividend Yield xxx N/A 1.9% xxx
Div Pay Ratio(%) xxx 115.3% 51.1% xxx

Dividend yield today if purchased 3 years ago: 2.42%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.74

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - 8.5c (100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201520162017201820192020
EPS Basic xxxxxxxxxxxxxxx15.3
DPS All xxxxxxxxxxxxxxx17.6
Sales/Revenue xxxxxxxxxxxxxxx1,832 M

EPS Basic

DPS All

Sales/Revenue

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.6

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxxxxx xx xxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

09/03/2021

1

Outperform

$10.55

4.56%

Macquarie notes ALS continues to do well with a strong update highlighting the improvement in the commodities business and resilience in the life sciences segment. This is in stark contrast to the earnings hit experienced by companies like Orica ((ORI)) and Worley ((WOR)).

The broker notes ALS's share price has been weak owing to a softer gold price and the impact of covid on emerging markets. Even so, looking at the latest update, the broker remains positive.

Outperform retained. Target falls to $10.55 from $10.65.

FORECAST
Macquarie forecasts a full year FY21 dividend of 19.10 cents and EPS of 36.10 cents.
Macquarie forecasts a full year FY22 dividend of 24.20 cents and EPS of 41.10 cents.

Credit Suisse

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

ALQ STOCK CHART